These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7527882)

  • 1. Detection of aneuploid cells in acute lymphoblastic leukemia with flow cytometry before and after therapy.
    Nowak R; Oelschlägel U; Hofmann R; Zengler H; Huhn R
    Leuk Res; 1994 Dec; 18(12):897-901. PubMed ID: 7527882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of combined DNA/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukemia cells in bone marrow.
    Nowak R; Oelschlaegel U; Schuler U; Zengler H; Hofmann R; Ehninger G; Andreeff M
    Cytometry; 1997 Feb; 30(1):47-53. PubMed ID: 9056742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DRC1 expression on normal and pathological lymphoid cells.
    Antoine N; Heinen E; Marcoty C; Bosseloir A; Simar L
    Adv Exp Med Biol; 1993; 329():449-53. PubMed ID: 7691033
    [No Abstract]   [Full Text] [Related]  

  • 4. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
    Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
    Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of residual aneuploid leukemic cells by "continuous gating".
    Kleine HD; Zech I; Nowak R; Oelschlägel U; Kundt G; Freund M
    Cytometry; 1999 May; 36(1):71-6. PubMed ID: 10331629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
    Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
    Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting.
    Irving J; Jesson J; Virgo P; Case M; Minto L; Eyre L; Noel N; Johansson U; Macey M; Knotts L; Helliwell M; Davies P; Whitby L; Barnett D; Hancock J; Goulden N; Lawson S; ;
    Haematologica; 2009 Jun; 94(6):870-4. PubMed ID: 19377076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of intracellular lymphoid differentiation antigens by flow cytometry in acute lymphoblastic leukemia.
    Sartor M; Bradstock K
    Cytometry; 1994 Sep; 18(3):119-22. PubMed ID: 7813331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridging the gap between the north and south of the world: the case of treatment response in childhood acute lymphoblastic leukemia.
    Stanulla M; Schrauder A
    Haematologica; 2009 Jun; 94(6):748-52. PubMed ID: 19483150
    [No Abstract]   [Full Text] [Related]  

  • 10. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
    Koníková E; Kusenda J; Babusíková O; Glasová M
    Neoplasma; 1995; 42(5):227-34. PubMed ID: 8552200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering stage 0 hematogones by flow cytometry in follow-up bone marrow samples of pediatric B-Acute lymphoblastic leukemia cases: A potential mimicker of residual disease after anti CD19 therapy.
    Ramalingam TR; Vaidhyanathan L; Muthu A; Swaminathan VV; Uppuluri R; Raj R
    Cytometry B Clin Cytom; 2024 Mar; 106(2):92-98. PubMed ID: 38243626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone.
    Gupta N; Parihar M; Banerjee S; Brahma S; Pawar R; Rath A; Shewale S; Singh M; Sasikumaran Nair Remani A; Krishnan S; Bhatacharyya A; Das A; Kumar J; Bhave S; Radhakrishnan V; Nair R; Chandy M; Mishra D; Arora N
    Cytometry B Clin Cytom; 2019 Sep; 96(5):359-367. PubMed ID: 30715800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of minimal residual disease in leukemia using flow cytometry].
    Muroi K
    Rinsho Ketsueki; 2008 Jun; 49(6):397-407. PubMed ID: 18646607
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow involvement in non-Hodgkin's lymphoma: increased diagnostic sensitivity by combination of immunocytology, cytomorphology and trephine histology.
    Schwonzen M; Pohl C; Steinmetz T; Wickramanayake PD; Thiele J; Diehl V
    Br J Haematol; 1992 Jul; 81(3):362-9. PubMed ID: 1382545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy.
    Digiuseppe JA
    Clin Lab Med; 2007 Sep; 27(3):533-49, vi. PubMed ID: 17658406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study.
    Larramendy M; el-Rifai W; Saarinen U; Alitalo R; Luomahaara S; Knuutila S
    Exp Hematol; 1995 Dec; 23(14):1563-7. PubMed ID: 8542947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical significance of detecting minimal residual disease in acute childhood B-cell lymphoblastic leukemia with flow cytometry].
    Zhang LP; Cheng YF; Liu GL; Lu AD; Liu YR; Wang H
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):481-5. PubMed ID: 16083543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
    Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
    Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.